ArticleMolecular cancer therapeutics2022

A FZD7-specific Antibody-Drug Conjugate Induces Ovarian Tumor Regression in Preclinical Models.

Myan Do et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.